--- title: "北海康成-B 發佈中期業績,期內溢利 5923.8 萬元 同比扭虧為盈" description: "北海康成-B 發佈截至 2025 年 6 月 30 日的中期業績,期內溢利為 5923.8 萬元,同比扭虧為盈。收益為 2224.8 萬元,同比減少 50.33%。公告指出,收入減少主要因公司戰略專注於罕見病,賀儷安®在台灣的銷售停止。此外,2025 年上半年實施積極存貨管理,減少了邁芮倍®的庫存。每股盈利為 0.14 元。" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/255350523.md" published_at: "2025-08-31T10:15:04.000Z" --- # 北海康成-B 發佈中期業績,期內溢利 5923.8 萬元 同比扭虧為盈 > 北海康成-B 發佈截至 2025 年 6 月 30 日的中期業績,期內溢利為 5923.8 萬元,同比扭虧為盈。收益為 2224.8 萬元,同比減少 50.33%。公告指出,收入減少主要因公司戰略專注於罕見病,賀儷安®在台灣的銷售停止。此外,2025 年上半年實施積極存貨管理,減少了邁芮倍®的庫存。每股盈利為 0.14 元。 智通財經 APP 訊,北海康成-B(01228) 發佈截至 2025 年 6 月 30 日止 6 個月中期業績,該集團取得收益 2224.8 萬元,同比減少 50.33%;期內溢利 5923.8 萬元,去年同期則取得虧損 2.47 億元;每股盈利 0.14 元。 公告稱,收入減少主要由於本公司原計劃於 2021 年戰略性專注於罕見病,於 2024 年底賀儷安®分銷協議終止後賀儷安®在台灣銷售停止。除賀儷安®在台灣的銷售外,我們的收益較 2024 年同期減少 170 萬元或 6.9%,主要由於 2025 年上半年北海康成實施積極存貨管理,並在渠道中減少邁芮倍®的庫存。 ### Related Stocks - [01228.HK - 北海康成-B](https://longbridge.com/zh-HK/quote/01228.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Guotai Haitong Sticks to Its Buy Rating for Shenzhen Edge Medical Co., Ltd. Class H (2675) | Guotai Haitong analyst maintained a Buy rating on Shenzhen Edge Medical Co., Ltd. Class H yesterday and set a price targ | [Link](https://longbridge.com/zh-HK/news/275997117.md) | | Greenland's west coast posts warmest January on record | Greenland's capital Nuuk recorded its warmest January ever, surpassing a 109-year-old record, with an average temperatur | [Link](https://longbridge.com/zh-HK/news/276050659.md) | | MAP: Which states have the most measles cases in 2026? | In 2026, the U.S. faces over 900 confirmed measles cases across nearly half the states, with five new outbreaks reported | [Link](https://longbridge.com/zh-HK/news/276010501.md) | | America can avoid a public health crisis by saving this one alert system | The National Health and Nutrition Examination Survey (NHANES) is a crucial public health tool that has uncovered signifi | [Link](https://longbridge.com/zh-HK/news/276008948.md) | | One year of RKF Jr.: How his MAHA agenda has reshaped US public health | Health and Human Services Secretary Robert F. Kennedy Jr. has completed his first year in office, implementing significa | [Link](https://longbridge.com/zh-HK/news/275944745.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。